본문 바로가기
KERD
논문KCI 등재

비소세포 폐암종의 상피성장인자 수용체 상태와 임상-병리학적 연관성: 단백 발현, 유전자 증폭 및 생존분석

Clinicopathologic Analysis of Epidermal Growth Factor Receptor Status in Non-small Cell Lung Cancer: ProteinExpression, Gene Amplification and Survival Analysis

2

조회

0

다운로드

1

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : Abnormal over-expression or gene amplification of epidermal growth factor receptor (EGFR) is important in the prognosis of non-small cell lung cancer (NSCLC). We investigated the frequency of EGFR protein expression and gene amplification, and the correlation between EGFR status and survival in NSCLC. Methods : We examined 360 cases of microarrayed NSCLC tissues for the EGFR protein expression and EGFR gene amplification using immunohistochemistry and fluorescent in situ hybridization. Results : EGFR protein expression and EGFR gene amplification occurred in 110 cases (30.6%) and 24 cases (6.7%), respectively. EGFR protein expression and gene amplification were more frequent in squamous cell carcinoma than in adenocarcinoma. Differences in EGFR protein expression did not dramatically affect survival curves (p=0.740), but differences in gene amplification did (p<0.05): EGFR gene amplification was associated with a lower 5-year survival rate. Conclusion : EGFR protein expression and gene amplification showed moderate correlation with each other. EGFR gene amplification predicted a poor prognosis, whereas EGFR protein expression did not.

참고문헌 (26)

  1. "Cancer burden in the year 2000 The global picture", 37, pp.4~66 (2001)
  2. "Cancer statistics, 2005", 55, pp.10~30 (2005)
  3. "Molecular pathogenesis of lung cancer", 118, pp.1136~1152 (1999)
  4. "Role of epidermal growth factor in carcinogenesis", pp.1030~7
  5. "Epidermal growth factor receptors in lung tumours", pp.297~307
  6. "A novel approach in the treatment of cancer targeting the epidermal growth factor receptor", 7, pp.2958~2570 (2001)
  7. "EGFR and cancer prognosis", 37, pp.9~15 (2001)
  8. "Matrix metalloproteinase 9 and theepidermal growth factor signal pathway in operable non-small celllung cancer", 6, pp.2349~2355 (2000)
  9. "The Relationship between expressionof EGFR and c-erbB-2 and survival time in resected nonsmallcell lung cancer", 59, pp.286~297 (2005)
  10. "Epidermalgrowth factor receptor family in lung cancer and premalignancy", 29, pp.3~14 (2002)
  11. "Epidermal growthfactor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis", 21, pp.3798~387 (2003)
  12. "Survival impactof epidermal growth factor receptor overexpression in patients withnon-small cell lung cancer: a meta-analysis", 61, pp.140~145 (2006)
  13. "Epidermal growthfactor receptor expression in squamous cell lung carcinomas animmunohistochemical and gene analysis in formalin-fixed", pp.295~302
  14. "Clinicopathologic features andprognostic implications of epidermal growth factor receptor (EGFR)gene copy number and protein expression in non-small cell lungcancer", 54, pp.387~398 (2006)
  15. "Amplificationand overexpression of the cyclin D1 and epidermal growthfactor receptor genes in non small-cell lung cancer Lung Cancer Study Group", 125, pp.61~70 (1999)
  16. "Correlation between moleculargenetic analyses and immunohistochemical evaluation of theepidermal growth factor receptor and p185HER2", 18, pp.2529~2534 (1998)
  17. "Protein overexpression and gene amplification of epidermal growthfactor receptor in nonsmall cell lung carcinomas An immunohistochemicaland fluorescence in situ hybridization study", 103, pp.1265~1273 (2005)
  18. "Lack of prognostic significanceof epidermal growth factor receptor and the oncoproteinp185HER-2 in patients with systemically untreated non-small-celllung cancer an immunohistochemical study on cryosections", 74, pp.86~91 (1996)
  19. "Overexpression of the epidermal growth factor receptorand its ligand transforming growth factor alpha is frequent inresectable non-small cell lung cancer but does not predict tumorprogression", 3, pp.515~522 (1997)
  20. "Isthere a relationship between c-erbB-1 and c-erbB-2 amplification andprotein overexpression in NSCLC?", 47, pp.325~336 (2005)
  21. "Significance of EGFR proteinexpression and gene amplification in non-small cell lung carcinoma", 125, pp.860~865 (2006)
  22. "Epidermal growth factor receptor dependence in humantumors more than just expression?", 7, pp.31~39 (2002)
  23. "Epidermal growth factor receptor in ovarian tumours correlationof immunohistochemistry with ligand binding assay", pp.1015~21
  24. "p38 MAP kinase mediates stress-induced internalization of EGFR:implications for cancer chemotherapy", 25, pp.4195~4206 (2006)
  25. "Validation of tissue microarraytechnology in breast carcinoma", 80, pp.1943~1949 (2000)
  26. "Tissue array method for large scale clinicopathologicstudy", 36, pp.199~204 (2002)

관련 논문AI추천

비소세포폐암종에서 EGFR 단백 발현과 유전자 증폭이제피티닙 치료에 미치는 영향강석진, 김성환, 김치홍, 김훈교, 심병용, 안명임, 유진영, 이경지, 정지한, 조규도, 조덕곤대한병리학회 · Journal of Pathology and Translational Medicine2008 · 제42권 제1호비소세포암종의 Epidermal Growth Factor Receptor발현과 EGFR 돌연변이와의 관계김미진, 석상희대한병리학회 · Journal of Pathology and Translational Medicine2008 · 제42권 제2호면역조직화학적 염색 방법에 따른 상피세포 성장 수용체 단백(EGFR)의 발현정도의 차이 및 EGFR의 발현정도와 EGFR 유전자의 돌연변이와의 상관관계에 대한 고찰김극준, 김상희, 김현용, 석상희, 송호정, 윤인숙, 이은화, 이태종대한임상검사과학회 · 대한임상검사과학회지2007 · 제39권 제3호비소세포 폐암종에서 Survivin의 발현 - 예후 및 종양 표지자와의 상관성-정민정, 천봉권대한병리학회 · Journal of Pathology and Translational Medicine2005 · 제39권 제3호Analysis of Mutations in Epidermal Growth Factor Receptor Gene in Korean Patients with Non-small Cell Lung Cancer: Summary of a Nationwide Survey김교영, 김미진, 김완섭, 김한겸, 노미숙, 서정욱, 성순희, 오미혜, 이건국, 이교영, 이상화, 이창훈, 장세진, 장순희, 정순희, 최유덕, 한정호, 김루시아대한병리학회 · Journal of Pathology and Translational Medicine2015 · 제49권 제6호초기단계의 비소세포폐암종에서 Telomerase ReverseTranscriptase 단백발현이 예후지표인자로서 가지는 의의박경신, 유진영, 이교영, 이아원, 정지한, 정찬권대한병리학회 · Journal of Pathology and Translational Medicine2007 · 제41권 제2호

이 간행물의 다른 논문 (12건)